MHC Gamma-Block SNP Matching to Reduce Severe Acute GVHD
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current HLA matching methods for transplant donors and recipients are inadequate in reducing the risk of graft-versus-host disease (GVHD), particularly severe acute GVHD, and improving survival outcomes, as they do not account for the genetic diversity within the MHC gamma block.
Innovation Solution
Identifying and matching single nucleotide polymorphisms (SNPs) in the MHC gamma block between HLA-B/C and HLA-DRB/DQB blocks to determine a compatible donor, using techniques like PCR-SSP assays and oligonucleotide probes to analyze genomic DNA for specific SNPs such as C2321, T9763, C9796, etc.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If HLA matching methods are used for transplant donor and recipient selection, then transplant compatibility is improved, but the risk of severe acute GVHD is not sufficiently reduced
Solution Approach 1:
The MHC region is segmented into distinct genomic blocks (alpha, beta, gamma, delta) with specific recombination hot spots. The invention focuses on the gamma block containing C2, C4, and Bf genes, analyzing SNPs within this specific segment to identify haplotype mismatches that HLA typing alone cannot detect, thereby reducing GVHD risk while maintaining transplant compatibility
Solution Approach 2:
The invention adds a new dimension to transplant matching by incorporating SNP analysis within the gamma block beyond traditional HLA allele matching. This dimensional expansion from HLA level to SNP level within specific genomic blocks enables detection of haplotype mismatches that were previously undetectable, providing more comprehensive compatibility assessment
2Loss of information
If microarray hybridization with oligonucleotide probes is used to detect physical linkage between HLA alleles, then haplotype matching information is obtained, but the method is not suitable for routine HLA typing
Solution Approach 1:
The invention extracts the essential function of microarray hybridization (detecting SNP genotypes) and implements it through simplified PCR-based methods. By focusing on specific SNP positions within the gamma block using allele-specific PCR amplification and gel electrophoresis, the complex microarray process is replaced with routine molecular biology techniques that can be easily performed in clinical laboratories
Solution Approach 2:
The invention creates simplified copies of the microarray functionality through PCR amplification of specific SNP regions. Instead of using complex oligonucleotide probe arrays, the method uses PCR primers that amplify and reveal SNP genotypes through gel electrophoresis patterns, providing the same haplotype matching information through a much simpler, routine-applicable process
3Adaptability or versatility
If HLA-matched donors are selected without considering MHC gamma block SNPs, then donor availability is increased, but survival outcomes are not optimized
Solution Approach 1:
The invention performs preliminary SNP genotyping of potential donors at the gamma block loci before final donor selection. By determining the presence or absence of specific SNPs (such as those in C2, C4, and Bf genes) in advance, the method identifies haplotype mismatches early in the screening process, allowing selection of donors who are both available and genetically compatible, thereby optimizing survival outcomes without unduly restricting donor pool
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Reduces the risk of GVHD and improves survival rates by ensuring HLA-mismatched donors have compatible MHC gamma block SNPs, particularly reducing severe acute GVHD and increasing the duration of transplant recipient survival.
Implementation Method 1
hybridized to microarrays containing oligonucleotide probes configured to detect physical linkage between the HLA alleles
Data Source
AI summary
The present disclosure relates to the identification of single nucleotide polymorphisms (SNPs) in the Gamma genomic block in the central region of the major histocompatibility complex (MHC) that can be used for matching transplant donors and recipients and determining disease susceptibility.